TABLE 5.
Case | Cytological finding | HPV type(s) | HPV type(s) determined by:
|
Pathology | |
---|---|---|---|---|---|
Direct sequencing | Other verification method | ||||
5 | Normal | 51 | 51 | NA | |
7 | Normal | 59 | NAd | 59b | NA |
24 | Normal | 16 | 16 | NA | |
52 | Normal | 52 | 33 | NA | |
89 | Normal | 39 | 39 | NA | |
92 | Normal | 56 | NA | NA | |
107 | Normal | 18, 52 | 52 | NA | |
110 | Normal | 52 | 52 | NA | |
114 | Normal | 18 | 18 | NA | |
186 | ASCUS | 52 | 52 | Negative | |
187 | Normal | 52 | 52 | NA | |
217 | Normal | 56, 62 | 56 | NA | |
229 | ASCUS | 18 | NA | 18b | NA |
295 | ASCUS | 52 | 52 | Negative | |
299 | LSIL | 16, 52 | 52 | CIN1 | |
300 | Normal | 52 | 52 | CIN1 | |
317 | LSIL | 16 | 16 | 16, 18c | NA |
363 | Normal | 45, 58, CP8304 | 58 | NA | |
364 | Normal | 16, 66 | 16 | NA | |
383 | Normal | 16, 31 | NA | 16, 31c | NA |
n = 20. The 13 high-risk types were HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, -56, -58, -59, and -68.
Type-specific PCR.
Paraffin-embedded cervical biopsy tissue for HPV genotyping using HPV Blot.
NA, not applicable. The amount of PCR product was insufficient for direct sequencing.